
Horizon Therapeutics Public Company Investor Relations Material
Latest events

Q3 2022
Horizon Therapeutics Public Company

Investor Presentation
8 Aug, 2023

Q2 2023
8 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Horizon Therapeutics Public Limited Company
Access all reports
Horizon Therapeutics Public Limited Company was a biopharmaceutical company focused on the development and commercialization of treatments for rare, autoimmune, and severe inflammatory diseases. The company marketed a portfolio of therapies in North America and internationally. Horizon Therapeutics Public Limited Company was headquartered in Dublin, Ireland, and its shares were listed on the NASDAQ.
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
HZNP
Country
🇺🇸 United States